We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-1.79%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$37.5B
AUM Growth
-$6.38B
(-15%)
Cap. Flow
-$5.67B
Cap. Flow
% of AUM
-15.11%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
717
New
113
Increased
155
Reduced
240
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$259M |
| 2 |
Allstate
ALL
|
+$258M |
| 3 |
Mastercard
MA
|
+$187M |
| 4 |
Costco
COST
|
+$170M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$263M |
| 2 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$257M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$210M |
| 4 |
CIT
CIT Group Inc.
CIT
|
+$207M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.14% |
| 2 | Healthcare | 14.39% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
476
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.47M | 0.01% |
335,527
-78,906
| -19% | -$1.06M |
|
477
Fulcrum Therapeutics
FULC
$283M
| $4.46M | 0.01% |
188,651
+3,417
| +2% | +$48.4K |
|
478
ICICI Bank
IBN
$109B
| $4.45M | 0.01% |
235,117
+11,169
| +5% | +$223K |
|
479
Mirion Technologies
MIR
$3.9B
| $4.43M | 0.01% |
+548,482
| New | +$4.73M |
|
480
OSI Systems
OSIS
$3.72B
| $4.37M | 0.01% |
51,392
-96,319
| -65% | -$8.1M |
|
481
Outfront Media
OUT
$5.63B
| $4.32M | 0.01% |
154,395
+4,979
| +3% | +$128K |
|
|
RENT
482
Rent the Runway
RENT
$126M
| $4.29M | 0.01% |
+31,158
| New | +$3.65M |
|
|
EB
483
DELISTED
Eventbrite
EB
| $4.25M | 0.01% |
287,690
-213,209
| -43% | -$3.16M |
|
484
Warner Music
WMG
$13.1B
| $4.24M | 0.01% |
112,129
-99,245
| -47% | -$3.76M |
|
485
Distribution Solutions Group
DSGR
$1.6B
| $4.17M | 0.01% |
+216,534
| New | +$4.71M |
|
486
Sweetgreen
SG
$703M
| $4.17M | 0.01% |
130,267
+26,221
| +25% | +$762K |
|
487
Pulmonx
LUNG
$89.5M
| $4.15M | 0.01% |
167,276
-154,387
| -48% | -$3.99M |
|
488
Quanterix
QTRX
$175M
| $4.02M | 0.01% |
137,607
-158,885
| -54% | -$4.86M |
|
489
Protolabs
PRLB
$1.92B
| $3.94M | 0.01% |
+74,477
| New | +$3.92M |
|
490
Rocket Pharmaceuticals
RCKT
$376M
| $3.9M | 0.01% |
245,692
-1,043,313
| -81% | -$18M |
|
491
Beam Therapeutics
BEAM
$2.67B
| $3.7M | 0.01% |
64,569
+258
| +0.4% | +$16.9K |
|
|
LUXE
492
LuxExperience B.V.
LUXE
$1.13B
| $3.63M | 0.01% |
296,518
+45,369
| +18% | +$688K |
|
|
CHUY
493
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $3.62M | 0.01% |
+134,020
| New | +$3.72M |
|
494
Salesforce
CRM
$156B
| $3.5M | 0.01% |
16,476
-2,341
| -12% | -$504K |
|
495
Snap
SNAP
$9.74B
| $3.22M | 0.01% |
+89,354
| New | +$3.23M |
|
496
Turning Point Brands
TPB
$1.56B
| $3.16M | 0.01% |
92,871
-1,000,982
| -92% | -$33.9M |
|
497
Wingstop
WING
$3.55B
| $3.07M | 0.01% |
26,172
-17,563
| -40% | -$2.49M |
|
|
HOUS
498
DELISTED
Anywhere Real Estate
HOUS
| $3.04M | 0.01% |
193,975
+6,200
| +3% | +$104K |
|
499
Grupo Aeroportuario del Pacifico
PAC
$13B
| $2.73M | 0.01% |
16,963
+830
| +5% | +$117K |
|
|
MDRX
500
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.51M | 0.01% |
+111,309
| New | +$2.26M |
|
Similar funds
Lord, Abbett & Co's Q1 2022 Portfolio in Review
As of Q1 2022, Lord, Abbett & Co held 717 positions worth $37.5B, down 15% from $43.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.67B in Q1 2022, closing 120 positions and reducing 240 holdings. Its most notable exit was Netflix, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Shell worth $268M.
- Lord, Abbett & Co's largest Q1 2022 buy was Shell: 4,875,112 shares worth $268M.
- Lord, Abbett & Co added most to Mastercard in Q1 2022, an estimated $187M increase.
- Lord, Abbett & Co's biggest Q1 2022 reduction was SVB Financial Group, cutting an estimated $210M.
- Lord, Abbett & Co fully exited Netflix in Q1 2022, selling an estimated $263M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $37.5B portfolio in Q1 2022.
- Lord, Abbett & Co opened 113 new positions and closed 120 in Q1 2022.
- Lord, Abbett & Co's portfolio value fell 15% quarter-over-quarter to $37.5B.
Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.